FINAL REFUSAL - MAILED
mailed
on 07 Oct 2024
Last Applicant/ Owned by
SE-864 31 Matfors
SE
Serial Number
79380466 filed on 14th Aug 2023
Registration Number
N/A
Correspondent Address
Charlene M. Krogh
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
NORTHX BIOLOGICS
Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy prod Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research services, and technology advisory services related to pharmaceutical research and development, development of gene therapy products, and genetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Scientific apparatus and instruments being medical laboratory research instruments for controlling, measuring, accelerating, and transporting chemicals for use in biochemical and genetic research; Scientific apparatus and instruments, namely, apparatus and instruments being medical laboratory research instruments for use in gene therapy, plasmid DNA production, cell banking and DNA sequencing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; biological preparations for pharmaceutical purposes for the supply of and use in vaccines, cell and gene therapies, proteins, genetic biological materials; chemical preparations for pharmaceutical purposes for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; diagnostic preparations for pharmaceutical purposes; medicine; biological preparations for medical purposes; chemical preparations for medical purposes; diagnostic preparations for medical purposes; preparations for medical use, in particular preparations for use in gene therapy, namely, for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; biological reagents for medical use; advanced therapy medicinal products, namely, therapeutic pharmaceuticals for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; somatic cell therapy products, namely, muscle cells, blood cells, skin cells and nerve cells gene therapy products, namely, virus, viral vector, and plasmid DNA material to be used in gene therapy applications; regenerative medicine products, namely, therapeutic pharmaceuticals for the for supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; personalized medicine products, namely, therapeutic pharmaceuticals for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; cell-based preparations, namely, plasmid DNA and mRNA cell therapy productions for medical purposes; nucleic acid preparations being nucleic acid sequences for medical purposes; vaccines; recombinant proteins arrays for medical diagnosis purposes; therapeutic antibodies for medical purposes; microbial expressed protein arrays for medical diagnosis purposes; DNA vaccines; DNA plasmids being vaccines or gene therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemicals used in industry and science, especially proteins, enzymes and modifications thereof
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79380466
Mark Type
No Service Mark
Attorney Docket Number
No T312794.IB-U
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Oct 2024 | FINAL REFUSAL E-MAILED |
| 07th Oct 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 07th Oct 2024 | FINAL REFUSAL WRITTEN |
| 20th Aug 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 20th Aug 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 20th Aug 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 02th Aug 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 22nd May 2024 | REFUSAL PROCESSED BY IB |
| 28th Apr 2024 | REFUSAL PROCESSED BY MPU |
| 28th Apr 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |